Institut de cancérologie de l'Ouest

Angers 49100

3 studies enrolling now · 4 studies all time

What they study most

Cancer of the Prostate, Carcinoma, Transitional Cell, Fallopian Tube Neoplasms, Glioblastoma Multiforme, Hormone Sensitive Prostate Cancer, Metastatic Castration Sensitive Prostate Cancer (mCSPC), Neoplasm Metastasis, Ovarian Neoplasms, Peritoneal Neoplasms, Prostate Cancer, Urinary Bladder Neoplasms

Studies at this site

• A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer — Recruiting now
• This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve. — Recruiting now
• A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract — Recruiting now
• Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM — Completed